This document provides guidelines for the assessment and treatment of fertility problems from the National Institute for Health and Care Excellence (NICE). It defines infertility as not conceiving after one year of unprotected sex. It recommends earlier specialist referral for women aged 36 or older or those with known infertility issues. Initial testing includes semen analysis, tests of ovarian reserve, and confirming ovulation. Lifestyle changes around weight, smoking, alcohol and caffeine are advised. Medical management is recommended for hypogonadism, while unproven drugs for idiopathic issues are not advised. Testing for viral infections is recommended prior to fertility treatments.
Diagnosis and classification of tubal factor infertilitySanjay Makwana
This document discusses tubal factor infertility (TFI), including causes such as damage from injury or pelvic inflammatory disease. It evaluates various diagnostic tests for TFI like hysterosalpingography (HSG), laparoscopy, and chlamydial antibody testing. Treatment options discussed include expectant management, antibiotics, tubal surgery like cannulation or anastomosis, and IVF. The evidence for different approaches is limited, with no randomized controlled trials directly comparing treatments. The conclusion is that IVF is generally the best treatment for older patients or more severe TFI, while surgery may be considered for milder cases or proximal tubal obstruction.
Ovarian reserve refers to the reproductive potential left within a woman's two ovaries based on number and quality of eggs. Diminished ovarian reserve is the loss of normal reproductive potential in the ovaries due to a lower count or quality of the remaining eggs
Management of Endometrioma- Current UpdateSujoy Dasgupta
Invited Lecture by Dr Sujoy Dasgupta in the Webinar on "Update on Endometriosis" organized by AICC RCOG (All India Coordinating Committee of Royal College of Obstetricians and Gynaecologists) East Zone, held in December, 2021
This document discusses tuboplasty, a procedure to recanalize fallopian tubes after sterilization. It presents a study evaluating the success of tuboplasty performed through a mini-laparotomy incision. 38 patients underwent the procedure between 2010-2014. On follow up, 30 patients (79%) showed bilateral spillage on hydrotubation, and 8 (21%) showed unilateral spillage. On HSG after 3 months, 28 patients (78%) showed bilateral tubal patency and 8 (22%) showed unilateral patency. The mini-laparotomy approach offers advantages over conventional and laparoscopic tuboplasty such as less tissue injury, fewer adhesions, and faster recovery.
Uterine-Sparing Surgery for Adenomyosis Prof. Aboubakr ElnasharAboubakr Elnashar
This document discusses uterine-sparing surgery for adenomyosis to improve fertility. It describes how adenomyosis can negatively impact fertility and IVF success rates. There are two types of uterine-sparing surgery discussed - complete excision (adenomyomectomy) for localized adenomyosis and partial excision (cytoreductive surgery) for diffuse adenomyosis. The techniques, indications, complications, and outcomes of these surgeries are examined, including improved fertility and pregnancy rates compared to hormonal therapies. However, risks like uterine rupture during subsequent pregnancy must be considered. Overall, the document concludes uterine-sparing surgery is a feasible option for improving fertility in qualified patients with adenomyosis, but it requires
Ovarian Stimulation in IUI- Overview Sr. Jyoti BhaskarLifecare Centre
The document discusses ovarian stimulation protocols for intrauterine insemination (IUI) in subfertile women. It provides information on the rationale for controlled ovarian hyperstimulation (COH) in IUI, including increasing the number of eggs and overcoming subtle defects. The aim of COH is to recruit multiple follicles, control ovulation timing, prevent premature LH surges, time insemination, and increase pregnancy rates. Optimal stimulation results in 2-3 follicles ≥18-19mm in size and a thick, trilaminar endometrium. Gonadotropins are more effective than anti-estrogens like clomiphene citrate for IUI, and low
Diagnosis and classification of tubal factor infertilitySanjay Makwana
This document discusses tubal factor infertility (TFI), including causes such as damage from injury or pelvic inflammatory disease. It evaluates various diagnostic tests for TFI like hysterosalpingography (HSG), laparoscopy, and chlamydial antibody testing. Treatment options discussed include expectant management, antibiotics, tubal surgery like cannulation or anastomosis, and IVF. The evidence for different approaches is limited, with no randomized controlled trials directly comparing treatments. The conclusion is that IVF is generally the best treatment for older patients or more severe TFI, while surgery may be considered for milder cases or proximal tubal obstruction.
Ovarian reserve refers to the reproductive potential left within a woman's two ovaries based on number and quality of eggs. Diminished ovarian reserve is the loss of normal reproductive potential in the ovaries due to a lower count or quality of the remaining eggs
Management of Endometrioma- Current UpdateSujoy Dasgupta
Invited Lecture by Dr Sujoy Dasgupta in the Webinar on "Update on Endometriosis" organized by AICC RCOG (All India Coordinating Committee of Royal College of Obstetricians and Gynaecologists) East Zone, held in December, 2021
This document discusses tuboplasty, a procedure to recanalize fallopian tubes after sterilization. It presents a study evaluating the success of tuboplasty performed through a mini-laparotomy incision. 38 patients underwent the procedure between 2010-2014. On follow up, 30 patients (79%) showed bilateral spillage on hydrotubation, and 8 (21%) showed unilateral spillage. On HSG after 3 months, 28 patients (78%) showed bilateral tubal patency and 8 (22%) showed unilateral patency. The mini-laparotomy approach offers advantages over conventional and laparoscopic tuboplasty such as less tissue injury, fewer adhesions, and faster recovery.
Uterine-Sparing Surgery for Adenomyosis Prof. Aboubakr ElnasharAboubakr Elnashar
This document discusses uterine-sparing surgery for adenomyosis to improve fertility. It describes how adenomyosis can negatively impact fertility and IVF success rates. There are two types of uterine-sparing surgery discussed - complete excision (adenomyomectomy) for localized adenomyosis and partial excision (cytoreductive surgery) for diffuse adenomyosis. The techniques, indications, complications, and outcomes of these surgeries are examined, including improved fertility and pregnancy rates compared to hormonal therapies. However, risks like uterine rupture during subsequent pregnancy must be considered. Overall, the document concludes uterine-sparing surgery is a feasible option for improving fertility in qualified patients with adenomyosis, but it requires
Ovarian Stimulation in IUI- Overview Sr. Jyoti BhaskarLifecare Centre
The document discusses ovarian stimulation protocols for intrauterine insemination (IUI) in subfertile women. It provides information on the rationale for controlled ovarian hyperstimulation (COH) in IUI, including increasing the number of eggs and overcoming subtle defects. The aim of COH is to recruit multiple follicles, control ovulation timing, prevent premature LH surges, time insemination, and increase pregnancy rates. Optimal stimulation results in 2-3 follicles ≥18-19mm in size and a thick, trilaminar endometrium. Gonadotropins are more effective than anti-estrogens like clomiphene citrate for IUI, and low
Ovarian reserve refers to the reproductive potential left within a woman's two ovaries based on number and quality of eggs. Diminished ovarian reserve is the loss of normal reproductive potential in the ovaries due to a lower count or quality of the remaining eggs
Surgical Management of Uterine AbnormalityUlun Uluğ
This document discusses the surgical management of uterine abnormalities. It begins by defining congenital genital abnormalities and Mullerian anomalies. It then provides classifications for uterine anomalies and discusses their prevalence. Various uterine anomalies are described in more detail, including their associated symptoms, prevalence, and effects on pregnancy outcomes. The document discusses diagnostic challenges and various treatment approaches for different uterine anomalies, particularly for septate uteri. It concludes that management must be individualized based on each patient's anatomy and clinical situation.
ENDOMETRIAL PREPARATION IN FROZEN EMBRYO TRANSFER CYCLESAboubakr Elnashar
This document discusses different methods for endometrial preparation in frozen embryo transfer (FET) cycles. It describes natural cycle FET, which can be done through a true natural cycle or modified natural cycle with an HCG trigger. It also outlines artificial/hormone replacement cycle FET, where estrogen and progesterone are administered without GnRH agonists in patients with remaining ovarian function. The key points are that the endometrium must be adequately prepared prior to embryo transfer, and the age of the embryos after thawing should correspond to the developmental age of the endometrium. The best method varies between patients and there is no clear consensus.
This document provides an overview of intrauterine insemination (IUI). Some key points include:
IUI is a first-line, non-invasive fertility treatment that involves placing processed sperm directly into the uterus. Success rates range from 6-20% depending on the stimulation protocol used. Factors like age, infertility duration and etiology, and semen quality impact success rates. Strict monitoring is important to minimize risks of ovarian hyperstimulation syndrome while maximizing pregnancy chances. Proper sperm processing techniques and timing of insemination relative to ovulation are also important considerations for IUI.
Fertility preservation options are important for cancer patients of reproductive age undergoing treatment. For women, established options include embryo freezing for married patients and oocyte freezing for single patients, both of which require delaying cancer treatment. Ovarian tissue freezing can be done at any age or relationship status and does not delay treatment, but reimplantation success is currently low. For pre-pubertal patients, ovarian tissue or testicular tissue freezing are the only available options. Future methods may allow in vitro gamete maturation or stem cell derived gametes. Multidisciplinary care and individualized counseling are key to help patients preserve their fertility whenever possible before cancer treatment.
The method of ovulation induction selected by the clinician should be based upon the underlying cause of anovulation and the efficacy, costs, risks, burden of treatment, and potential complications associated with each method as they apply to the individual woman. In this presentation I have mentioned every points in detail.
IVF – ICSI in PCOS DIFFICULTIES AND SOLUTIONS Dr. Sharda Jain Dr. Jyoti Bha...Lifecare Centre
This document discusses challenges and solutions for IVF-ICSI treatment in patients with polycystic ovarian syndrome (PCOS). It covers several topics, including:
1) Selection of PCOS patients for IVF by ensuring failure of first and second line ovulation induction treatments or laparoscopic ovarian drilling plus failure of three IUIs.
2) Pre-IVF workup including ruling out other conditions and optimizing general health by addressing obesity, insulin resistance, and other issues.
3) Pre-IVF treatments like weight loss, metformin use, oral contraceptives, and possible laparoscopic ovarian drilling to help with ovarian stimulation and prevent ovarian hyperstimulation syndrome (OHSS).
Dr. Laxmi Shrikhande is a renowned fertility specialist in India. She has received many prestigious awards and has held numerous leadership positions in national OB/GYN societies. She has extensive experience conducting research and publishing papers in national and international journals. She is highly skilled in IUI and optimizing outcomes through proper patient selection, semen preparation techniques, ovulation timing, and insemination procedures.
Laparoscopy still remains an important diagnostic and therapeutic tool in the management of subfertile women. Optimal and prudent use of this minimally invasive technique may avert costly treatment like IVF but overzealous and unindicated use may compromise future fertility. The evidence indicates that laparoscopic surgery improves fertility outcomes for conditions like mild to moderate endometriosis, myomectomy for submucosal fibroids, and tubal surgery. However, more high-quality randomized controlled trials are needed to provide stronger evidence and guidelines for clinical practice in reproductive surgery.
DNB Obstetrics & gynaecology previous Year Question Papersapollobgslibrary
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive functioning. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms.
Since the first formal description of LPD in 1949 as a possible cause of infertility and recurrent miscarriage by Jones. Innumerable investigations have been undertaken in an effort to verify its existence or to characterize its pathophysiology, diagnosis, and treatment. The consensus of the literature is that LPD does exist and that its cause is multifactorial like abnormal folliculogenesis, inadequate LH surge,inadequate secretion of progesterone by the corpus luteum, aberrant end-organ response by the endometrium.
IUI is a basic but effective form of fertiltiy treatment and can be a viable alternative to the expensive IVF / test tube baby treatment that is normally advised.
This presentation will be very useful for the practising gynecologists, IVF specialists and General practitioners who perform IUI.
Even patients on going through this presentation will be more educated about iui.
Please reach out to me on 9833032120 by whatsapp / Telegram or phone call or email on dalalsj@gmail.com for further details / treatment options.
Medical Management of fibroid focus on Low Does Mifepristone Dr Sharda Jain D...Lifecare Centre
This document provides information about the medical management of uterine fibroids using low dose mifepristone. It summarizes the credentials and experience of Dr. Sharda Jain and Dr. Jyoti Agarwal in treating fibroids. It discusses the limitations of current surgical and medical treatments for fibroids. Low dose mifepristone is presented as a promising alternative that is shown to reduce fibroid size and symptoms by inhibiting progesterone and stimulating apoptosis of fibroid cells. The document shares the experience of treating 53 patients with low dose mifepristone and recommends it as an option prior to fibroid surgery to improve outcomes.
The document discusses infertility treatment related to polycystic ovary syndrome (PCOS). Lifestyle modifications like weight loss and increased physical activity are recommended as first-line treatment for obesity in PCOS patients. Clomiphene citrate is the first choice for ovulation induction, while gonadotropins and laparoscopic ovarian drilling are recommended as second-line treatments if clomiphene citrate fails. In vitro fertilization is an effective third-line treatment option for infertility in women with PCOS, as it can achieve pregnancy while minimizing the risk of multiple pregnancies.
1) The use of tocolytic drugs is associated with prolonging pregnancy up to 7 days but does not significantly impact preterm birth rates or neonatal outcomes.
2) Tocolysis should only be considered if delaying birth will allow for completing a course of corticosteroids or in utero transfer to another hospital.
3) Nifedipine and atosiban are effective tocolytic options, with fewer maternal side effects than beta-agonists, though long-term neonatal outcomes remain unclear for all tocolytic drugs.
This document discusses types of anovulation and treatments for infertility related to anovulation. It describes the main types of anovulation as hypogonadotropic hypoestrogenic, normogonadotrophic normoestrogenic (PCOS), and hypergonadotrophic hypoestrogenic. Investigations for determining the type include progesterone, FSH, LH, prolactin and thyroid tests. Treatments include lifestyle changes, oral contraceptives, metformin, gonadotropins, clomiphene citrate, and IVF depending on the type and severity of the case. The document also outlines types of ovarian stimulation and drugs commonly used for ovarian stimulation.
The document discusses different measures of fertility including total fertility rate (TFR), birth rate, and crude birth rate. It then lists factors that can influence fertility rates such as education, culture, religion, economic conditions, health issues, and government policy. These influencing factors are grouped into sociocultural and economic categories. Tables are presented comparing fertility rates and percentages of women of childbearing age by country income level and over time. Examples of sociocultural influences include religion, disease prevalence, and women's status. Economic influences discussed include costs of childrearing and type of prevailing economy.
Ovarian reserve refers to the reproductive potential left within a woman's two ovaries based on number and quality of eggs. Diminished ovarian reserve is the loss of normal reproductive potential in the ovaries due to a lower count or quality of the remaining eggs
Surgical Management of Uterine AbnormalityUlun Uluğ
This document discusses the surgical management of uterine abnormalities. It begins by defining congenital genital abnormalities and Mullerian anomalies. It then provides classifications for uterine anomalies and discusses their prevalence. Various uterine anomalies are described in more detail, including their associated symptoms, prevalence, and effects on pregnancy outcomes. The document discusses diagnostic challenges and various treatment approaches for different uterine anomalies, particularly for septate uteri. It concludes that management must be individualized based on each patient's anatomy and clinical situation.
ENDOMETRIAL PREPARATION IN FROZEN EMBRYO TRANSFER CYCLESAboubakr Elnashar
This document discusses different methods for endometrial preparation in frozen embryo transfer (FET) cycles. It describes natural cycle FET, which can be done through a true natural cycle or modified natural cycle with an HCG trigger. It also outlines artificial/hormone replacement cycle FET, where estrogen and progesterone are administered without GnRH agonists in patients with remaining ovarian function. The key points are that the endometrium must be adequately prepared prior to embryo transfer, and the age of the embryos after thawing should correspond to the developmental age of the endometrium. The best method varies between patients and there is no clear consensus.
This document provides an overview of intrauterine insemination (IUI). Some key points include:
IUI is a first-line, non-invasive fertility treatment that involves placing processed sperm directly into the uterus. Success rates range from 6-20% depending on the stimulation protocol used. Factors like age, infertility duration and etiology, and semen quality impact success rates. Strict monitoring is important to minimize risks of ovarian hyperstimulation syndrome while maximizing pregnancy chances. Proper sperm processing techniques and timing of insemination relative to ovulation are also important considerations for IUI.
Fertility preservation options are important for cancer patients of reproductive age undergoing treatment. For women, established options include embryo freezing for married patients and oocyte freezing for single patients, both of which require delaying cancer treatment. Ovarian tissue freezing can be done at any age or relationship status and does not delay treatment, but reimplantation success is currently low. For pre-pubertal patients, ovarian tissue or testicular tissue freezing are the only available options. Future methods may allow in vitro gamete maturation or stem cell derived gametes. Multidisciplinary care and individualized counseling are key to help patients preserve their fertility whenever possible before cancer treatment.
The method of ovulation induction selected by the clinician should be based upon the underlying cause of anovulation and the efficacy, costs, risks, burden of treatment, and potential complications associated with each method as they apply to the individual woman. In this presentation I have mentioned every points in detail.
IVF – ICSI in PCOS DIFFICULTIES AND SOLUTIONS Dr. Sharda Jain Dr. Jyoti Bha...Lifecare Centre
This document discusses challenges and solutions for IVF-ICSI treatment in patients with polycystic ovarian syndrome (PCOS). It covers several topics, including:
1) Selection of PCOS patients for IVF by ensuring failure of first and second line ovulation induction treatments or laparoscopic ovarian drilling plus failure of three IUIs.
2) Pre-IVF workup including ruling out other conditions and optimizing general health by addressing obesity, insulin resistance, and other issues.
3) Pre-IVF treatments like weight loss, metformin use, oral contraceptives, and possible laparoscopic ovarian drilling to help with ovarian stimulation and prevent ovarian hyperstimulation syndrome (OHSS).
Dr. Laxmi Shrikhande is a renowned fertility specialist in India. She has received many prestigious awards and has held numerous leadership positions in national OB/GYN societies. She has extensive experience conducting research and publishing papers in national and international journals. She is highly skilled in IUI and optimizing outcomes through proper patient selection, semen preparation techniques, ovulation timing, and insemination procedures.
Laparoscopy still remains an important diagnostic and therapeutic tool in the management of subfertile women. Optimal and prudent use of this minimally invasive technique may avert costly treatment like IVF but overzealous and unindicated use may compromise future fertility. The evidence indicates that laparoscopic surgery improves fertility outcomes for conditions like mild to moderate endometriosis, myomectomy for submucosal fibroids, and tubal surgery. However, more high-quality randomized controlled trials are needed to provide stronger evidence and guidelines for clinical practice in reproductive surgery.
DNB Obstetrics & gynaecology previous Year Question Papersapollobgslibrary
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive functioning. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms.
Since the first formal description of LPD in 1949 as a possible cause of infertility and recurrent miscarriage by Jones. Innumerable investigations have been undertaken in an effort to verify its existence or to characterize its pathophysiology, diagnosis, and treatment. The consensus of the literature is that LPD does exist and that its cause is multifactorial like abnormal folliculogenesis, inadequate LH surge,inadequate secretion of progesterone by the corpus luteum, aberrant end-organ response by the endometrium.
IUI is a basic but effective form of fertiltiy treatment and can be a viable alternative to the expensive IVF / test tube baby treatment that is normally advised.
This presentation will be very useful for the practising gynecologists, IVF specialists and General practitioners who perform IUI.
Even patients on going through this presentation will be more educated about iui.
Please reach out to me on 9833032120 by whatsapp / Telegram or phone call or email on dalalsj@gmail.com for further details / treatment options.
Medical Management of fibroid focus on Low Does Mifepristone Dr Sharda Jain D...Lifecare Centre
This document provides information about the medical management of uterine fibroids using low dose mifepristone. It summarizes the credentials and experience of Dr. Sharda Jain and Dr. Jyoti Agarwal in treating fibroids. It discusses the limitations of current surgical and medical treatments for fibroids. Low dose mifepristone is presented as a promising alternative that is shown to reduce fibroid size and symptoms by inhibiting progesterone and stimulating apoptosis of fibroid cells. The document shares the experience of treating 53 patients with low dose mifepristone and recommends it as an option prior to fibroid surgery to improve outcomes.
The document discusses infertility treatment related to polycystic ovary syndrome (PCOS). Lifestyle modifications like weight loss and increased physical activity are recommended as first-line treatment for obesity in PCOS patients. Clomiphene citrate is the first choice for ovulation induction, while gonadotropins and laparoscopic ovarian drilling are recommended as second-line treatments if clomiphene citrate fails. In vitro fertilization is an effective third-line treatment option for infertility in women with PCOS, as it can achieve pregnancy while minimizing the risk of multiple pregnancies.
1) The use of tocolytic drugs is associated with prolonging pregnancy up to 7 days but does not significantly impact preterm birth rates or neonatal outcomes.
2) Tocolysis should only be considered if delaying birth will allow for completing a course of corticosteroids or in utero transfer to another hospital.
3) Nifedipine and atosiban are effective tocolytic options, with fewer maternal side effects than beta-agonists, though long-term neonatal outcomes remain unclear for all tocolytic drugs.
This document discusses types of anovulation and treatments for infertility related to anovulation. It describes the main types of anovulation as hypogonadotropic hypoestrogenic, normogonadotrophic normoestrogenic (PCOS), and hypergonadotrophic hypoestrogenic. Investigations for determining the type include progesterone, FSH, LH, prolactin and thyroid tests. Treatments include lifestyle changes, oral contraceptives, metformin, gonadotropins, clomiphene citrate, and IVF depending on the type and severity of the case. The document also outlines types of ovarian stimulation and drugs commonly used for ovarian stimulation.
The document discusses different measures of fertility including total fertility rate (TFR), birth rate, and crude birth rate. It then lists factors that can influence fertility rates such as education, culture, religion, economic conditions, health issues, and government policy. These influencing factors are grouped into sociocultural and economic categories. Tables are presented comparing fertility rates and percentages of women of childbearing age by country income level and over time. Examples of sociocultural influences include religion, disease prevalence, and women's status. Economic influences discussed include costs of childrearing and type of prevailing economy.
Management of infertility Nice Guidelines 2013 : Dr. Sharda Jain Dr. Jyoti ...Lifecare Centre
1) The guidelines provide recommendations for the management of infertility including advice and counseling, lifestyle changes, ovulation induction, IUI, IVF criteria and genetic counseling.
2) Key recommendations include weight loss and lifestyle changes for PCOS, a maximum of 6 months of ovulation induction before considering other options, offering 3 cycles of IVF to those under 40 who have not conceived after 2 years, and genetic counseling and testing before ICSI.
3) The guidelines aim to optimize treatment effectiveness while minimizing risks like multiple pregnancies and OHSS.
This document discusses infertility, including its definition, causes, evaluation, and management. It notes that infertility affects approximately 1 in 7 couples in the UK. Evaluation involves assessing both partners for potential medical causes through history, examination, tests, and procedures. Treatment options range from lifestyle changes to surgery to assisted reproductive technologies (ART) like IVF, depending on the underlying cause. The majority of young couples without known issues will conceive naturally within 2 years.
This document discusses measures of fertility. It begins by defining fecundity and fertility in demography. It then outlines several key measures used to quantify birth performance and compare fertility levels, including crude birth rate (CBR), general fertility rate (GFR), general marital fertility rate (GMFR), age specific fertility rate (ASFR), total fertility rate (TFR), gross reproduction rate (GRR), and net reproduction rate (NRR). The document explains how to compute each of these measures and highlights their uses and limitations. It concludes by discussing replacement level fertility.
Infertility affects couples worldwide, with an average incidence of about 15%. Evaluation of both female and male partners is essential to determine the cause, which can be female factors, male factors, or a combination. Treatment options depend on the cause and range from ovulation-inducing drugs, surgery, and assisted reproductive technologies like in vitro fertilization.
Men and women can both be infertile, and the cause of infertility varies in women and men. For women, the cause of infertility ranges from diseases of the thyroid to fibroids in the uterus and even endometriosis.
Infertility is defined as the failure to conceive after 12 months of unprotected sex. It can be caused by issues with either the man or woman's reproductive systems. Common causes include fallopian tube damage, ovulation disorders, low sperm count/quality, and age-related decline in fertility. Diagnosis involves medical history, physical exams, and tests like semen analysis and ultrasound. Treatment may include lifestyle changes, fertility drugs, artificial insemination, in vitro fertilization, and surrogacy. Preventing infertility requires a healthy diet, exercise, stress management, avoiding drugs/excessive alcohol, and considering age-related fertility decline.
This document provides an overview of infertility, including its definition, types, incidence, risk factors, diagnosis, treatment, and the role of midwives. It defines infertility as the inability to conceive after one year of unprotected sex. Various female and male factors that can cause infertility are described. Diagnostic tests for both men and women are outlined. Treatment options include lifestyle changes, fertility drugs, surgery, and assisted reproductive technologies like IUI, IVF, and ICSI. The importance of infertility counseling to help couples cope with emotional aspects is also discussed.
In you have any question about infertility treatment so you should read these notes. I tried my best to mention all possible Q and A about infertility treatment.
Explore the intricacies of ovulation induction in intrauterine insemination (IUI) with Dr Laxmi Shrikhande's informative slide share presentation. From understanding the hormonal mechanisms to the latest techniques, this presentation offers insights into optimizing fertility through IUI. Whether you're a clinician seeking to enhance patient outcomes or an individual navigating fertility treatments, this resource provides valuable knowledge for your journey towards conception.
This document discusses infertility, including its definition, causes, evaluation, and management. It notes that infertility affects approximately 1 in 7 couples in the UK. Evaluation involves assessing both partners for potential medical causes through history, examination, labs, and imaging. Treatment depends on the underlying cause, and may include lifestyle changes, medical therapy, surgery, or assisted reproductive technologies like ovulation induction, IUI, IVF, and ICSI. The document emphasizes the importance of counseling and stresses that most young couples will conceive naturally within 2 years without intervention.
Infertility is inability to achieve pregnancy after 12 months of having unprotected sexual intercourse with average frequency of 3 to 4 times per week with no use of any birth control measures.Female Infertility refers to Infertility in women. It affects an estimated 48 million women, with the highest prevalence of infertility affecting women in South Asia, Sub-Saharan Africa, North Africa/Middle East, and Central/Eastern Europe and Central Asia . Infertility is caused by many sources, including nutrition, diseases, and other malformations of the uterus.
Treatment:
No alcoholism
Maintaining good BMI
Have intercourse during midcycle
Detect LH surge in urine
Assurance
No smoking
Using drugs
Therapies
Surgeries
Good mental health
This document summarizes guidelines for screening and treatment related to gynecologic health in menopausal women. It discusses recommendations and risks for cervical and breast cancer screening, as well as guidelines for and risks of hormone replacement therapy. It also reports on non-hormonal options for treating post-menopausal symptoms like hot flashes. The document provides this information through a series of clinical vignettes and recommendations based on evidence from sources like the USPSTF.
If you\'re struggling to have a baby, Fertility Partnership outlines the causes behind infertility and the many possible treatments available to help you have the baby of your dreams.
This document provides information about fertility issues, treatments, and the Fertility Partnership clinic. It discusses common causes of infertility for both men and women. It also outlines fertility treatments that may be used, including diagnostic procedures, ovulation induction, IUI, IVF and more. The document promotes the Fertility Partnership clinic as offering these treatments at lower costs than other clinics using the latest technologies. It introduces the clinic staff and describes their experience in fertility care.
Diagnostic evaluation of the infertile femaleAsaad Hashim
This document provides an overview of the diagnostic evaluation process for an infertile female. It discusses the typical causes of female infertility, including ovulatory disorders, endometriosis, pelvic adhesions, and tubal blockage. The evaluation involves assessing the reproductive axis through history, physical exam, tests of ovarian reserve, ovulation, tubal patency, and detection of uterine or peritoneal abnormalities. Common tests include hormonal assays, ultrasound, hysterosalpingography, laparoscopy, and semen analysis of the male partner. The goal is to identify any treatable causes of infertility and guide treatment decisions.
Case Based Panel Discussion on Menopausal healthSujoy Dasgupta
Dr Sujoy Dasgupta moderated a panel on "Case Based Panel Discussion on Menopausal health" in the CME on Menopausal Health, organized by the AICC RCOG (All India Coordinating Committee) East Zone, held in Kolkata in March, 2022
presentation on infertility, causes and its management. it gives an idea of the scope of the problem especially in sub Saharan Africa . the challenges in its management.
menstrual manipulation for adolescents with disabilityMini Sood
A presentation of aspects of menstrual care in adolescents including those with disability. Slides for medical students who may encounter young patients who are unable to mange their menses efficiently
This document provides guidance on in vitro fertilization (IVF) treatment for people with fertility problems. It discusses factors that can predict IVF success, long-term safety considerations, access criteria for IVF treatment, and protocols for various stages of IVF including ovarian stimulation, embryo transfer, and luteal phase support. The goal is to help people make informed decisions about IVF and improve outcomes for those undergoing fertility treatment.
This document outlines the key aspects of focused antenatal care (ANC) according to the World Health Organization (WHO) model. It discusses the traditional ANC model and introduces the focused ANC model, which aims to provide evidence-based care through 4 routine visits. Each visit is described in detail, outlining objectives, components of history, physical exam, tests, interventions, and advice. The overall goal of focused ANC is to promote health, detect and treat complications early, and ensure preparedness for birth.
This document discusses menopause and hormone replacement therapy (HRT). It covers the physiology of menopause, clinical features, case studies, diagnosis, assessment, management of menopause symptoms, benefits and risks of HRT, alternative treatments, and management of comorbidities. Key points include how menopause is diagnosed based on symptoms and lab tests, options for treating vasomotor symptoms like hot flashes, risks and benefits of HRT need to be discussed, and alternative treatments or adjustments to HRT may be considered for individual cases.
This document summarizes a case of a 21-year-old female with primary amenorrhea and hot flashes. Her lab tests showed elevated FSH and LH levels consistent with premature ovarian insufficiency. The document defines premature ovarian insufficiency as cessation of menses before age 40 due to depletion or dysfunction of ovarian follicles. It discusses causes, risk factors, symptoms, diagnosis, and treatment options which include hormone replacement therapy and in vitro fertilization with donor eggs. Counseling is recommended to address psychological and family planning aspects.
MBC Support Group for Black Women – Insights in Genetic Testing.pdfbkling
Christina Spears, breast cancer genetic counselor at the Ohio State University Comprehensive Cancer Center, joined us for the MBC Support Group for Black Women to discuss the importance of genetic testing in communities of color and answer pressing questions.
Michigan HealthTech Market Map 2024. Includes 7 categories: Policy Makers, Academic Innovation Centers, Digital Health Providers, Healthcare Providers, Payers / Insurance, Device Companies, Life Science Companies, Innovation Accelerators. Developed by the Michigan-Israel Business Accelerator
Gemma Wean- Nutritional solution for Artemiasmuskaan0008
GEMMA Wean is a high end larval co-feeding and weaning diet aimed at Artemia optimisation and is fortified with a high level of proteins and phospholipids. GEMMA Wean provides the early weaned juveniles with dedicated fish nutrition and is an ideal follow on from GEMMA Micro or Artemia.
GEMMA Wean has an optimised nutritional balance and physical quality so that it flows more freely and spreads readily on the water surface. The balance of phospholipid classes to- gether with the production technology based on a low temperature extrusion process improve the physical aspect of the pellets while still retaining the high phospholipid content.
GEMMA Wean is available in 0.1mm, 0.2mm and 0.3mm. There is also a 0.5mm micro-pellet, GEMMA Wean Diamond, which covers the early nursery stage from post-weaning to pre-growing.
International Cancer Survivors Day is celebrated during June, placing the spotlight not only on cancer survivors, but also their caregivers.
CANSA has compiled a list of tips and guidelines of support:
https://cansa.org.za/who-cares-for-cancer-patients-caregivers/
Unlocking the Secrets to Safe Patient Handling.pdfLift Ability
Furthermore, the time constraints and workload in healthcare settings can make it challenging for caregivers to prioritise safe patient handling Australia practices, leading to shortcuts and increased risks.
We are one of the top Massage Spa Ajman Our highly skilled, experienced, and certified massage therapists from different corners of the world are committed to serving you with a soothing and relaxing experience. Luxuriate yourself at our spas in Sharjah and Ajman, which are indeed enriched with an ambiance of relaxation and tranquility. We could confidently claim that we are one of the most affordable Spa Ajman and Sharjah as well, where you can book the massage session of your choice for just 99 AED at any time as we are open 24 hours a day, 7 days a week.
Visit : https://massagespaajman.com/
Call : 052 987 1315
Comprehensive Rainy Season Advisory: Safety and Preparedness Tips.pdfDr Rachana Gujar
The "Comprehensive Rainy Season Advisory: Safety and Preparedness Tips" offers essential guidance for navigating rainy weather conditions. It covers strategies for staying safe during storms, flood prevention measures, and advice on preparing for inclement weather. This advisory aims to ensure individuals are equipped with the knowledge and resources to handle the challenges of the rainy season effectively, emphasizing safety, preparedness, and resilience.
At Malayali Kerala Spa Ajman, Full Service includes individualized care for every client. We specifically design each massage session for the individual needs of the client. Our therapists are always willing to adjust the treatments based on the client's instruction and feedback. This guarantees that every client receives the treatment they expect.
By offering a variety of massage services, our Ajman Spa Massage Center can tackle physical, mental, and emotional illnesses. In addition, efficient identification of specific health conditions and designing treatment plans accordingly can significantly enhance the quality of massaging.
At Malayali Kerala Spa Ajman, we firmly believe that everyone should have the option to experience top-quality massage services regularly. To achieve that goal we offer cheap massage services in Ajman.
If you are interested in experiencing transformative massage treatment at Malayali Kerala Spa Ajman, you can use our Ajman Massage Center WhatsApp Number to schedule your next massage session.
Contact @ +971 529818279
Visit @ https://malayalikeralaspaajman.com/
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDr Rachana Gujar
Introduction: Substance use education is crucial due to its prevalence and societal impact.
Alcohol Use: Immediate and long-term risks include impaired judgment, health issues, and social consequences.
Tobacco Use: Immediate effects include increased heart rate, while long-term risks encompass cancer and heart disease.
Drug Use: Risks vary depending on the drug type, including health and psychological implications.
Prevention Strategies: Education, healthy coping mechanisms, community support, and policies are vital in preventing substance use.
Harm Reduction Strategies: Safe use practices, medication-assisted treatment, and naloxone availability aim to reduce harm.
Seeking Help for Addiction: Recognizing signs, available treatments, support systems, and resources are essential for recovery.
Personal Stories: Real stories of recovery emphasize hope and resilience.
Interactive Q&A: Engage the audience and encourage discussion.
Conclusion: Recap key points and emphasize the importance of awareness, prevention, and seeking help.
Resources: Provide contact information and links for further support.
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...Ear Solutions (ESPL)
Binaural hearing using two hearing aids instead of one offers numerous advantages, including improved sound localization, enhanced sound quality, better speech understanding in noise, reduced listening effort, and greater overall satisfaction. By leveraging the brain’s natural ability to process sound from both ears, binaural hearing aids provide a more balanced, clear, and comfortable hearing experience. If you or a loved one is considering hearing aids, consult with a hearing care professional at Ear Solutions hearing aid clinic in Mumbai to explore the benefits of binaural hearing and determine the best solution for your hearing needs. Embracing binaural hearing can lead to a richer, more engaging auditory experience and significantly improve your quality of life.
At Apollo Hospital, Lucknow, U.P., we provide specialized care for children experiencing dehydration and other symptoms. We also offer NICU & PICU Ambulance Facility Services. Consult our expert today for the best pediatric emergency care.
For More Details:
Map: https://cutt.ly/BwCeflYo
Name: Apollo Hospital
Address: Singar Nagar, LDA Colony, Lucknow, Uttar Pradesh 226012
Phone: 08429021957
Opening Hours: 24X7
Pediatric Emergency Care for Children | Apollo Hospital
NICE Fertility Guideline
1. Presented by:
Dr. Fatema Tuz Zahura Aalpona
Assessment and Treatment for People
with Fertility Problems
NICE Clinical Guideline 156
Issued: February 2013
2. Definition of Infertility
A woman of reproductive age who has not conceived
after 1 year of unprotected vaginal sexual
intercourse, in the absence of any known cause of
infertility, should be offered further clinical assessment
and investigation along with her partner.
3. Earlier referral for specialist consultation
The woman is aged 36 years or over
There is a known clinical cause of infertility or a
history of predisposing factors for infertility
4. Principles of care
Couples who experience problems in conceiving
should be seen together
They have the opportunity to make informed
decisions regarding their care and treatment via
access to evidence-based information
Information regarding care and treatment options
should be provided in a form that is accessible to
people who have additional needs (physical, cognitive
or sensory disabilities, or inability to speak or read).
5. Psychological effects of fertility problems
Stress can affect their relationship and can
contribute to the fertility problems
It is helpful to contact a fertility support group
Counseling should be offered as fertility problems
themselves & investigation and treatment can cause
psychological stress
6. Psychological effects of fertility problems
Counseling is offered before, during and after
investigation and treatment, irrespective of the
outcome of these procedures.
Counseling is provided by someone who is not
directly involved in the management of the
individual's and/or couple's fertility problems.
7. Generalist and Specialist Care
Infertile people should be treated by a specialist
team as it is likely to improve the effectiveness and
efficiency of treatment and is known to improve
people's satisfaction with treatment
9. Chance of conception
80% of couples in the general population will
conceive within 1 year if:
The woman is aged under 40 years and
They do not use contraception and have regular
sexual intercourse.
Of those who do not conceive in the first year, about
half will do so in the second year (cumulative
pregnancy rate over 90%).
10. Chance of conception
People using artificial insemination to conceive should
be informed that:
over 50% of women under 40 years will conceive
within 6 cycles of intrauterine insemination (IUI)
of those who do not conceive within 6 cycles of IUI
about half will do so with a further 6 cycles
(cumulative pregnancy rate over 75%).
11. Frequency and timing of sexual intercourse
or artificial insemination
Vaginal sexual intercourse every 2 to 3days
optimizes the chance of pregnancy.
People using artificial insemination to conceive
should have their insemination timed around
ovulation.
12. Alcohol
Women should be informed that drinking no more
than 1 or 2 units of alcohol once or twice per week
and avoiding episodes of intoxication reduces the
risk of harming a developing fetus
Men should be informed that alcohol consumption of
3 to 4 units per day for men is unlikely to affect their
semen quality
Excessive alcohol intake is detrimental to semen
quality
13. Smoking
Women should be informed that smoking is likely to
reduce their fertility.
Referral to a smoking cessation program to support
their efforts in stopping smoking.
Passive smoking is likely to affect their chance of
conceiving.
Men are informed that there is an association
between smoking and reduced semen quality and
stopping smoking will improve their general health.
14. Caffeinated Beverages
No consistent evidence of an association between
consumption of caffeinated beverages (tea, coffee
and colas) and fertility problems.
15. Obesity
Women with BMI of 30 or over are likely to take
longer to conceive.
Losing weight is likely to increase their chance of
conception
Exercise and dietary advice leads to more
pregnancies than weight loss advice alone.
Men with BMI of 30 or over should be informed that
they are likely to have reduced fertility.
16. Low body weight
Women with BMI of less than 19 and who have
irregular menstruation or are not menstruating
should be advised that increasing body weight is
likely to improve their chance of conception
17. Occupation
Some occupations involve exposure to hazards
that can reduce male or female fertility and
therefore a specific enquiry about occupation and
appropriate advice should be offered
18. Prescribed, OTC & Recreational drug use
A number of prescription, over-the-counter and
recreational drugs interfere with male and female
fertility, and therefore a specific enquiry about these
and appropriate advice should be offered.
19. Folic acid supplementation
Women intending to become pregnant should be
informed that dietary supplementation with folic acid
before conception and up to 12 weeks' gestation
reduces the risk of having a baby with neural tube
defects. The recommended dose is 0.4mg per day.
For women who have previously had an infant with
a neural tube defect or who are receiving anti-
epileptic medication or who have diabetes, a higher
dose of 5 mg per day is recommended.
21. Semen analysis:
WHO reference values
Semen volume 1.5 ml or more
pH 7.2 or more
Sperm concentration 15 million spermatozoa per ml or
more
Total sperm number 39 million spermatozoa per
ejaculate or more
Total motility 40% or more motile or 32% or
more with progressive motility
Vitality 58% or more live spermatozoa
Sperm morphology
(% of normal forms)
4% or more
22. Abnormal result should be conformed by a repeat
test 3 months after the initial analysis to allow time for
the cycle of spermatozoa formation to be completed
However, if a gross spermatozoa deficiency
(azoospermia or severe oligozoospermia) has been
detected the repeat test should be undertaken as
soon as possible
Semen analysis:
23. Ovarian reserve testing
A woman's age is an initial predictor of her overall
chance of success through natural conception or
with IVF
Measures are used to predict the ovarian response to
gonadotrophin stimulation:
Total antral follicle count of ≤4 for a low response and
>16 for a high response
Anti-Müllerian hormone of ≤5.4pmol/l for a low
response and ≥25.0pmol/l for a high response
FSH >8.9IU/l for a low response and <4IU/l for a high
response
24. Confirming Ovulatory Cycles
Women with regular monthly menstrual cycle are
likely to be ovulating
Serum progesterone in the mid-luteal phase of their
cycle (day 21 of a 28-day cycle) to confirm ovulation
even if they have regular menstrual cycles
Women with prolonged irregular menstrual cycles
should be offered a serum progesterone test. This
test may need to be conducted later in the cycle (for
example day 28 of a 35-day cycle) and repeated
weekly thereafter until the next menstrual cycle starts
25. The use of basal body temperature charts to confirm
ovulation does not reliably predict ovulation and is
not recommended
Women with irregular menstrual cycles should be
offered a blood test to measure serum
gonadotrophins (follicle-stimulating hormone and
luteinising hormone)
Confirming Ovulatory Cycles
26. Prolactin measurement
Women who are concerned about their fertility should
not be offered a blood test to measure prolactin
This test should only be offered to women who have
an ovulatory disorder, galactorrhoea or a pituitary
tumour.
27. Thyroid function tests
Women with possible fertility problems are no more
likely than the general population to have thyroid
disease and the routine measurement of thyroid
function should not be offered
Estimation of thyroid function should be confined to
women with symptoms of thyroid disease
28. Investigation of suspected tubal and
uterine abnormalities
Women without co morbidities (e.g. PID, previous
ectopic preg. or endometriosis) should be offered
hysterosalpingography (HSG) to screen for tubal
occlusion as it is a reliable test and also less invasive
and makes more efficient use of resources than
laparoscopy
Where appropriate expertise is available,
hysterosalpingo-contrast-sonography should be
considered because it is an effective alternative to
HSG for women having no co morbidities
29. Women thought to have co morbidities should be
offered laparoscopy and dye test so that tubal and
other pelvic pathology can be assessed at the same
time.
Investigation of suspected tubal and
uterine abnormalities
30. Testing for viral status
People undergoing IVF treatment should be offered
testing for HIV, hepatitis B and hepatitis C
People found to positive for one or more of the
infections should be offered specialist advice,
counseling and appropriate clinical management
31. Viral transmission
HIV: For couples where the man is HIV positive, any
decision about fertility management should be the
result of discussions between the couple, a fertility
specialist and an HIV specialist
Hepatitis B: For partners of people with hepatitis B,
vaccination should be offered before starting fertility
treatment
Hepatitis C: For couples where the man has hepatitis
C, any decision about fertility management should be
the result of discussions between the couple, a fertility
specialist and a hepatitis specialist
32. Susceptibility to rubella
Women should be offered testing for their rubella
status so that those who are susceptible to rubella
can be offered vaccination.
After vaccination woman is advised not to become
pregnant for at least 1 month
34. Medical management: Male factor infertility
Men with hypogonadotrophic hypogonadism should be
offered gonadotrophin drugs
In idiopathic semen abnormalities should not be
offered antioestrogens, gonadotrophins, androgens,
bromocriptine or kinin-enhancing drugs as they have
not been shown to be effective
Men with leucocytes in their semen should not be
offered antibiotic treatment unless there is an
identified infection because there is no evidence that
this improves pregnancy rates
35. Surgical management: Male factor infertility
Obstructive azoospermia should be offered surgical
correction of epididymal blockage because it is likely to
improve fertility
Surgical correction should be considered as an
alternative to surgical sperm recovery & IVF
Surgery for varicoceles should not be offered as it does
not improve pregnancy rate
37. WHO Classification of Ovulatory Disorders
Group I: Hypothalamic pituitary failure (hypothalamic
amenorrhoea or hypogonadotrophic hypogonadism).
Group II: Hypothalamic-pituitary-ovarian dysfunction
(predominately polycystic ovary syndrome).
Group III: Ovarian failure
38. WHO Group I Ovulation Disorders
Can improve their chance of regular ovulation,
conception and an uncomplicated pregnancy by:
increasing their body weight if they have a BMI of less
than 19 and/or
moderating their exercise levels if they undertake high
levels of exercise
Women of this group should be offered:
pulsatile GnRH or
gonadotrophins with LH activity to induce ovulation
39. WHO Group II Ovulation Disorders:
Candidate for ovarian stimulation
Loose weight if BMI ≥30
Should be offered one of the following treatments:
Clomifene citrate or
Metformin or
A combination of the above
40. Clomifene citrate: ultrasound monitoring is needed
during at least the first cycle of treatment to ensure
that they are taking a dose that minimizes the risk of
multiple pregnancy
Clomifene citrate should not be continued for longer
than 6 months
Metformin: inform the side effects associated with
its use (such as nausea, vomiting and other
gastrointestinal disturbances)
WHO Group II Ovulation Disorders
41. One of the second-line treatments should be
considered, depending on clinical circumstances
and the woman's preference:
Laparoscopic ovarian drilling or
Combined treatment with clomifene citrate and
metformin if not already offered as first-line treatment
or
Gonadotrophins
WHO Group II Ovulation Disorders:
Resistant to clomifene citrate
42. Hyperprolactinaemic amenorrhoea
These women should be offered treatment with
dopamine agonists (such as bromocriptine)
Consideration should be given to safety for use in
pregnancy and minimizing cost when prescribing
43. Monitoring ovulation induction during
gonadotrophin therapy
Women should be informed about the risk of multiple
pregnancy and ovarian hyperstimulation before
starting treatment
Ovarian ultrasound monitoring to measure follicular
size and number should be an integral part of
gonadotrophin therapy to reduce the risk of multiple
pregnancy and ovarian hyperstimulation
45. Tubal Catheterization or Cannulation
For women with proximal tubal obstruction, following
may be treatment options because these treatments
improve the chance of pregnancy:
Selective salpingography plus tubal
catheterisation
Hysteroscopic tubal cannulation
46. Surgery for Hydrosalpinges before IVF
Salpingectomy should be offered, preferably by
laparoscopy, before IVF treatment because this
improves the chance of a live birth.
47. Uterine Surgery
Women with amenorrhoea due to intrauterine
adhesions should be offered hysteroscopic
adhesiolysis because this is likely to restore
menstruation and improve the chance of pregnancy
49. Ovarian stimulation for unexplained infertility
Oral ovarian stimulation agents (such as clomifene
citrate, letrozole) should not be offered
Clomifene citrate as a stand-alone treatment does
not increase the chances of a pregnancy or a live
birth
These women are advised of having regular
unprotected sexual intercourse for a total of 2 years
before IVF will be considered
50. Intrauterine Insemination (IUI): Indications
Unstimulated IUI is considered as a treatment option
in the following groups as an alternative to vaginal
intercourse:
Who are unable to, or find it very difficult to, have
vaginal intercourse because of physical disability or
psychosexual problem who are using partner or donor
sperm
In conditions that require specific consideration e.g.
after sperm washing where the man is HIV positive
In same-sex relationships
51. Who have not conceived after 6 cycles of donor or
partner insemination, despite normal ovulation, tubal
patency and semen analysis, should be offered a
further 6 cycles of unstimulated IUI before IVF is
considered
In case of unexplained infertility, mild endometriosis or
mild male factor infertility, who are having regular
unprotected sexual intercourse, routine IUI should not
be offered, either with or without ovarian stimulation
(exceptional circumstances include, for example,
when people have social, cultural or religious
objections to IVF)
Intrauterine Insemination (IUI): Indications
52. Female age: the chance of a live birth following IVF
treatment falls with rising female age.
Number of previous treatment cycles: overall
chance of a live birth following IVF treatment falls as
the number of unsuccessful cycles increases.
Previous pregnancy history: IVF treatment is more
effective in women who have past pregnancy and/or
had a live birth.
Body mass index: BMI should ideally be in the range
19–30 before commencing assisted reproduction
Prediction of IVF Success
54. Referral Criteria for IVF
Women under 40 years who have not conceived after 2
years of regular unprotected intercourse or 12 cycles of IUI,
3 full cycles of IVF, with/without ICSI are offered
If woman reaches the age of 40 during treatment, only the
current full cycle is completed
For women aged 40–42 years 1 full cycle of IVF, with or
without ICSI is offered, provided the following 3 criteria are
fulfilled:
They have never previously had IVF treatment
There is no evidence of low ovarian reserve
There has been a discussion of the additional
implications of IVF and pregnancy at this age
56. Down regulation and other regimens to
avoid premature luteinising hormone
surges in IVF
Either GNRH agonist down-regulation or GNRH
antagonists as part of gonadotrophin stimulated IVF
treatment cycles is used
57. Controlled ovarian stimulation in IVF
Either urinary or recombinant gonadotrophins is used
for ovarian stimulation
An individualized starting dose of FSH, based on
factors such as:
Age
BMI
Presence of polycystic ovaries
Ovarian reserve
A dose of FSH not more than 450IU/day is used
Ultrasound monitoring (with/without oestradiol levels)
58. Triggering Ovulation in IVF
HCG (urinary or recombinant) is used
Clinics providing ovarian stimulation with
gonadotrophins should have protocols in place for
preventing, diagnosing and managing ovarian
hyperstimulation syndrome (OHS)
59. Oocyte and Sperm Retrieval in IVF
Women undergoing transvaginal retrieval of oocytes
should be offered conscious sedation
Surgical sperm recovery before ICSI may be
performed using several different techniques
depending on the pathology and wishes of the man.
In all cases, facilities for cryopreservation of
spermatozoa should be available
60. Embryo Transfer Strategies in IVF
USG-guided embryo transfer because this improves
pregnancy rates
Replacement of embryos into a uterine cavity with an
endometrium of less than 5mm thickness is unlikely
to result in a pregnancy
61. Number of fresh or frozen embryos to transfer
For women aged under 37 years:
o In the first full IVF cycle - single embryo transfer
o In the second full IVF cycle - single embryo transfer if 1 or
more top-quality embryos are available. If no top-quality
embryos are available 2 embryos are used
o In the third full IVF cycle - no more than 2 embryos should
be transferred
For women aged 37–39 years:
o In the first and second full IVF cycles use single embryo
transfer if there are 1 or more top-quality embryos. Double
embryo transfer if there are no top-quality embryos
o In the third full IVF cycle transfer no more than 2 embryos
For women aged 40–42 years: double embryo transfer
62. Luteal Phase Support After IVF
Progesterone for luteal phase support after IVF
treatment up to 8 weeks
63. Indications for ICSI
The recognised indications are:
Severe deficits in semen quality
Obstructive azoospermia
Non-obstructive azoospermia
In addition, treatment by ICSI should be considered
for couples in whom a previous IVF cycle has
resulted in failed or very poor fertilisation
64. Donor Insemination
The use of donor insemination is considered effective
in managing fertility problems associated with-
obstructive azoospermia
non-obstructive azoospermia
Severe deficits in semen quality in couples who do
not wish to undergo ICSI
High risk of trasmitting genetic disease or infection to
the offsprings
Severe Rhesus isoimmunization
65. Oocyte Donation
The use of donor oocytes is considered effective in
managing fertility problems associated --
Premature ovarian failure
Gonadal dysgenesis, including Turner syndrome
Bilateral oophorectomy
Ovarian failure following chemotherapy/radiotherapy
Certain cases of IVF treatment failure
A high risk of transmitting a genetic disorder to the
offspring
66. People with cancer who wish to preserve fertility
At diagnosis, the impact of the cancer and its treatment on
future fertility should be discussed between the person
diagnosed with cancer and their cancer team.
When deciding to offer fertility preservation to people
diagnosed with cancer, the factors to be considered:
Diagnosis
Treatment plan
Expected outcome of subsequent fertility treatment
Prognosis of the cancer treatment
Viability of stored/post-thawed material
67. Sperm cryopreservation to men and adolescent boys
who are preparing for treatment of cancer that is
likely to make them infertile
Oocyte or embryo cryopreservation as appropriate to
women of reproductive age (including adolescent
girls) who are preparing for treatment for cancer that
is likely to make them infertile if:
They are well enough to undergo ovarian stimulation
and egg collection
This will not worsen their condition
Enough time is available before the start of their
cancer treatment
People with cancer who wish to preserve fertility
68. Long-term safety of assisted
reproductive technologies for
women with infertility and their
children
69. Long-term health outcomes of ovulation induction
and ovarian stimulation
Women who are offered ovulation induction or ovarian
stimulation should be informed that:
No direct association has been found between these
treatments and invasive cancer
No association has been found in the short- to
medium-term between these treatments and adverse
outcomes (including cancer) in children born from
ovulation induction
Information about long-term health outcomes in
women and children is still awaited
70. Long-term health outcomes and safety of IVF
Absolute risks of long-term adverse outcomes of IVF
treatment, with or without ICSI, are low, a small
increased risk of borderline ovarian tumours cannot
be excluded
People, considering IVF treatment should be
informed that that the absolute risks of long-term
adverse outcomes in children born as result of IVF
are low